<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.rcuk.ac.uk/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/83D87776-5958-42AE-889D-B8AECF16B468"><gtr:id>83D87776-5958-42AE-889D-B8AECF16B468</gtr:id><gtr:name>University of Leeds</gtr:name><gtr:address><gtr:line1>University of Leeds</gtr:line1><gtr:line4>Leeds</gtr:line4><gtr:line5>West Yorkshire</gtr:line5><gtr:postCode>LS2 9JT</gtr:postCode><gtr:region>Yorkshire and The Humber</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/F649AB83-DC92-4360-807F-BBFEF0DE8EE4"><gtr:id>F649AB83-DC92-4360-807F-BBFEF0DE8EE4</gtr:id><gtr:name>National Center for Scientific Research (Centre National de la Recherche Scientifique CNRS)</gtr:name></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.rcuk.ac.uk:80/organisation/4A348A76-B2D0-4DDD-804A-CE735A6D3798"><gtr:id>4A348A76-B2D0-4DDD-804A-CE735A6D3798</gtr:id><gtr:name>University of Bristol</gtr:name><gtr:department>Cellular and Molecular Medicine</gtr:department><gtr:address><gtr:line1>Senate House</gtr:line1><gtr:line4>Bristol</gtr:line4><gtr:line5>Avon</gtr:line5><gtr:postCode>BS8 1TH</gtr:postCode><gtr:region>South West</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/4A348A76-B2D0-4DDD-804A-CE735A6D3798"><gtr:id>4A348A76-B2D0-4DDD-804A-CE735A6D3798</gtr:id><gtr:name>University of Bristol</gtr:name><gtr:address><gtr:line1>Senate House</gtr:line1><gtr:line4>Bristol</gtr:line4><gtr:line5>Avon</gtr:line5><gtr:postCode>BS8 1TH</gtr:postCode><gtr:region>South West</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/83D87776-5958-42AE-889D-B8AECF16B468"><gtr:id>83D87776-5958-42AE-889D-B8AECF16B468</gtr:id><gtr:name>University of Leeds</gtr:name><gtr:address><gtr:line1>University of Leeds</gtr:line1><gtr:line4>Leeds</gtr:line4><gtr:line5>West Yorkshire</gtr:line5><gtr:postCode>LS2 9JT</gtr:postCode><gtr:region>Yorkshire and The Humber</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/F649AB83-DC92-4360-807F-BBFEF0DE8EE4"><gtr:id>F649AB83-DC92-4360-807F-BBFEF0DE8EE4</gtr:id><gtr:name>National Center for Scientific Research (Centre National de la Recherche Scientifique CNRS)</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/CE7344E9-9C5C-4527-8E38-3C4A0A4ADC14"><gtr:id>CE7344E9-9C5C-4527-8E38-3C4A0A4ADC14</gtr:id><gtr:firstName>Andrew</gtr:firstName><gtr:otherNames>Duell</gtr:otherNames><gtr:surname>Davidson</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.rcuk.ac.uk:80/projects?ref=G0401586"><gtr:id>1E024FF9-6D7D-41BC-AC66-C2783E3D008E</gtr:id><gtr:title>Structure function analysis of the Dengue virus capsid protein.</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>G0401586</gtr:grantReference><gtr:abstractText>Dengue is the most important mosquito-borne viral disease of humans with 50-100 million people infected annually worldwide. Dengue virus infection usually results in dengue fever, a mild ?flu? like illness. However, in some cases, patients may develop severe, potentially fatal complications known as dengue haemorrhagic fever/dengue shock syndrome (DHF/DSS). Despite intensive research over recent years, the disease processes leading to DHF/DSS are still poorly understood and there is neither a safe and effective vaccine nor suitable anti-viral treatments to control dengue disease.

This project aims to study the function/s of the dengue virus capsid protein in the virus lifecycle and its possible contribution to disease processes. Dengue virus particles consist of multiple copies of only three proteins. A lipid membrane containing two surface proteins surrounds an inner core consisting of the capsid protein and the viral RNA genome. Aside from its role in the formation of the virus particle, the capsid protein has also been found in the host cell nucleus where it has the potential to disturb host cell processes. We will use recent information about the three dimensional structure of the capsid protein, in combination with genetic engineering of the viral genome, to identify regions of the capsid protein essential to the virus lifecycle. By determining how these regions of the C protein function in the virus lifecycle, we will increase our understanding of dengue virus replication and disease, and provide knowledge that can be used to develop novel dengue vaccines and antiviral compounds. The results of this investigation will also be relevant to related flaviviruses such as West Nile virus, Yellow fever virus and tick-borne and Japanese encephalitis viruses which cause public health problems worldwide.

Staff at the University of Bristol are actively encouraged to communicate the results of their research to the general public. The results of University research is disseminated to the general public through articles in the publication ?re:search?, widely distributed in the community and by the organisation of research seminars open to the general public.</gtr:abstractText><gtr:technicalSummary>Dengue virus (DENV) is a mosquito borne flavivirus infecting 50-100 million individuals annually worldwide. Dengue disease ranges from mild fever to the potentially fatal dengue haemorrhagic fever/ shock syndromes. Despite intensive research over recent years, the pathogenesis of DHF/DSS is still poorly understood and there is neither a safe and effective vaccine nor suitable anti-viral treatments to control dengue disease. The DENV particle contains an RNA genome and three structural proteins (capsid, membrane and envelope). The capsid (C) protein plays an essential role in the virus structure, surrounding the genome to form the virus nucleocapsid. Moreover, although the DENV C protein is initially ER membrane associated, it also localises to the nucleus and evidence suggests that the DENV C protein interacts with and modulates the function of host cell factors. During 2004, detailed NMR and X-ray structural data has become available for the C protein, however the molecular determinants that govern the function of the C protein in the viral life cycle are largely unresolved. Recent studies have shown that flaviviruses containing engineered deletions in the C gene are attenuated and potentially novel and attractive candidates for the development of flavivirus vaccines. This proposal aims to use reverse genetics, in combination with recent C protein structural data, to identify specific regions and residues in the DENV C protein that interact with cellular and viral components. Furthermore, we will analyse how these interactions regulate viral replication and morphogenesis. By determining how specific regions of the C protein function in the virus lifecycle, we will increase our understanding of flavivirus replication and pathogenesis, and provide knowledge that can be used to develop novel dengue vaccines and antiviral compounds.</gtr:technicalSummary><gtr:fund><gtr:end>2009-02-27</gtr:end><gtr:funder url="http://gtr.rcuk.ac.uk:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2006-01-30</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>170000</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Leeds</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Faculty of Biological Sciences</gtr:department><gtr:description>Interaction of the dengue virus NS5 protein with RNA structures</gtr:description><gtr:id>7F9E19D6-5927-49EF-A5A6-961C89DB0A19</gtr:id><gtr:impact>Dynamic interactions between trans-activating factors and structured RNA during dengue virus replication.
Lauren Branfield, Andrew Davidson, Mark Harris, Anastasia Zhuravleva and Andrew Tuplin
Society of Microbiology Annual Conference, 2016

Dynamic interactions between trans-activating factors and structured RNA during dengue virus replication 
Lauren Branfield, Andrew Davidson, Chi Trinh, Mark Harris, Anastasia Zhuravleva and Andrew Tuplin
Society of Microbiology Annual Conference, 2017</gtr:impact><gtr:partnerContribution>Producing protein using the plasmid constructs, RNA interaction studies, proteins and RNA structural studies.</gtr:partnerContribution><gtr:piContribution>I have provided dengue virus genetic systems and plasmids encoding dengue virus proteins to the collaborator. i have also provided the collaborator with intellectual input that can be used to investigate host proteins involved in virus replication.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2015-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>National Center for Scientific Research (Centre National de la Recherche Scientifique CNRS)</gtr:collaboratingOrganisation><gtr:country>France, French Republic</gtr:country><gtr:department>Architecture and Function of Biological Macromolecules (AFMB)</gtr:department><gtr:description>Development of dengue virus replicons for antiviral drug screening.</gtr:description><gtr:id>D9D3A8A5-6FBA-41A0-AB97-49FBECB4632F</gtr:id><gtr:impact>Research paper: PMID: 20307577</gtr:impact><gtr:partnerContribution>Provision of reserach tools that are unpublished ie specific monoclnal antibodies.</gtr:partnerContribution><gtr:piContribution>Provided research systems for the development of high throughput antiviral drug screening</gtr:piContribution><gtr:sector>Academic/University</gtr:sector></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>School visit</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>3D4220DF-1E3F-49DC-B221-4CDAD0DFD900</gtr:id><gtr:impact>RW talked to 50 school students about her research and a career in science.

N/A</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:year>2008</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs/><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs><gtr:researchMaterialOutput><gtr:description>During the project an improved dengue virus replicon was produced. Dengue virus replicons are derived from the full dengue virus genome and allow cell based screening of dengue virus replicative functions in a biosafe manner.</gtr:description><gtr:id>B8660256-07B0-47C0-A615-575E791092DB</gtr:id><gtr:impact>The replicon has been used to develop high throughput drug screening systems for dengue virus.</gtr:impact><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>Dengue virus replicon</gtr:title><gtr:type>Technology assay or reagent</gtr:type><gtr:yearFirstProvided>2008</gtr:yearFirstProvided></gtr:researchMaterialOutput></gtr:researchMaterialOutputs><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/51BD3C53-D1FA-4EF5-8D46-6B8FE0C68302"><gtr:id>51BD3C53-D1FA-4EF5-8D46-6B8FE0C68302</gtr:id><gtr:title>Replication of not-known-vector flaviviruses in mosquito cells is restricted by intracellular host factors rather than by the viral envelope proteins.</gtr:title><gtr:parentPublicationTitle>The Journal of general virology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/7be15e9044c633d659877fbdf4a17c01"><gtr:id>7be15e9044c633d659877fbdf4a17c01</gtr:id><gtr:otherNames>Charlier N</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0022-1317</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/B073E466-5D56-47A1-8E91-8460D092DB5A"><gtr:id>B073E466-5D56-47A1-8E91-8460D092DB5A</gtr:id><gtr:title>Reverse genetics and the study of dengue virus</gtr:title><gtr:parentPublicationTitle>Future Virology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/66680813a1de0bc6e3dea2c6bc163cda"><gtr:id>66680813a1de0bc6e3dea2c6bc163cda</gtr:id><gtr:otherNames>Ward R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/1C62DDAF-1D4D-49DB-9F01-0474771B93CA"><gtr:id>1C62DDAF-1D4D-49DB-9F01-0474771B93CA</gtr:id><gtr:title>Both E protein glycans adversely affect dengue virus infectivity but are beneficial for virion release.</gtr:title><gtr:parentPublicationTitle>Journal of virology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/8033763ccfe8bc587cd808477d8fa410"><gtr:id>8033763ccfe8bc587cd808477d8fa410</gtr:id><gtr:otherNames>Lee E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0022-538X</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/93ACEBD1-D512-4E35-8812-60BDD9236F48"><gtr:id>93ACEBD1-D512-4E35-8812-60BDD9236F48</gtr:id><gtr:title>Sensing of immature particles produced by dengue virus infected cells induces an antiviral response by plasmacytoid dendritic cells.</gtr:title><gtr:parentPublicationTitle>PLoS pathogens</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/af15431fa34ac896e6a43fdb8ac4c9ed"><gtr:id>af15431fa34ac896e6a43fdb8ac4c9ed</gtr:id><gtr:otherNames>D?cembre E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1553-7366</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/0540F8E9-920E-42CF-A151-2DBF8D154872"><gtr:id>0540F8E9-920E-42CF-A151-2DBF8D154872</gtr:id><gtr:title>Construction and characterization of a stable subgenomic dengue virus type 2 replicon system for antiviral compound and siRNA testing.</gtr:title><gtr:parentPublicationTitle>Antiviral research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/12a91105554327bf453ba0bc5e3554bc"><gtr:id>12a91105554327bf453ba0bc5e3554bc</gtr:id><gtr:otherNames>Ng CY</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0166-3542</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/5E3CEC41-BB5C-4F7F-BAC2-22515A027333"><gtr:id>5E3CEC41-BB5C-4F7F-BAC2-22515A027333</gtr:id><gtr:title>Identification of a new dengue virus inhibitor that targets the viral NS4B protein and restricts genomic RNA replication.</gtr:title><gtr:parentPublicationTitle>Antiviral research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/652a6ed0f591b71d1631ff84160f58d8"><gtr:id>652a6ed0f591b71d1631ff84160f58d8</gtr:id><gtr:otherNames>van Cleef KW</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0166-3542</gtr:issn></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G0401586</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>03BA7BC9-C251-48FC-8EA9-5F7414A63FEE</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Infection</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>CDB856E6-DF2D-4D96-88BD-1CC96FE277EF</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>2.2  Factors relating to physical environment</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>